Sangamo Therapeutics
SGMO
#8837
Rank
NZ$0.26 B
Marketcap
NZ$0.78
Share price
3.81%
Change (1 day)
-81.11%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: NZ$0.26 Billion

As of December 2025 Sangamo Therapeutics has a market cap of NZ$0.26 Billion. This makes Sangamo Therapeutics the world's 8837th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$0.26 B-72.46%
2024NZ$0.94 B521.62%
2023NZ$0.15 B-81.2%
2022NZ$0.81 B-49.33%
2021NZ$1.59 B-47.71%
2020NZ$3.05 B112.24%
2019NZ$1.44 B-17.59%
2018NZ$1.74 B-10.39%
2017NZ$1.95 B527.64%
2016NZ$0.31 B-66.87%
2015NZ$0.93 B-30%
2014NZ$1.34 B27.43%
2013NZ$1.05 B171.41%
2012NZ$0.38 B103.01%
2011NZ$0.19 B-51.11%
2010NZ$0.39 B6.5%
2009NZ$0.36 B49.23%
2008NZ$0.24 B-64.14%
2007NZ$0.68 B108.74%
2006NZ$0.32 B82.15%
2005NZ$0.18 B-15.17%
2004NZ$0.21 B1.2%
2003NZ$0.20 B47.57%
2002NZ$0.14 B-74.16%
2001NZ$0.55 B-43.5%
2000NZ$0.97 B

End of Day market cap according to different sources

On Dec 19th, 2025 the market cap of Sangamo Therapeutics was reported to be:

NZ$0.26 Billion
by Nasdaq info icon info icon
NZ$0.26 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
NZ$267.83 B 102,568.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$91.82 B 35,101.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$306.15 B 117,260.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$44.53 B 16,971.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
NZ$28.71 B 10,906.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$863.49 B 330,904.91%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ$20.40 B 7,720.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$438.51 B 167,997.33%๐Ÿ‡บ๐Ÿ‡ธ USA